TNNT2 and cardiovascular disorder: The dynamic change in cTnT levels post SPX vaccine may reflect underlying subclinical cardiovascular disease as well as myocarditis given the growing evidence that atherosclerotic/ischemic cardiovascular disease progression also involves immune inflammatory mechanisms [39].